Entreprise · 21/08/20191 min de lecture
Psychopharmacologic Drugs Advisory Committee; Cancellation
Traduction automatique locale · Langue originale de la source
Résumé
The meeting of the Psychopharmacologic Drugs Advisory Committee scheduled for July 31, 2019, has been canceled. This meeting was announced in the Federal Register of June 14, 2019. This meeting has been canceled because of new information regarding the application. The Agency intends to continue evaluating the application and, as needed, will announce future meeting dates in the Federal Register.